With genome sequencing becoming more common, it is likely more cases of SYT-mediated neurological disorders will be found given a disruptive amino acid change in the C2B Ca2+-binding pocket in a single copy can cause disease. This evidence concerns the gene SYT1 and nervous system disorder.